DepEd, DOH launch mobile app for monitoring of Dengvaxia vaccinees

Marje Pelayo   •   July 17, 2018   •   3929

MANILA, Philippines – Dengvaxia vaccinees can now be monitored digitally online and in real time by parents and guardians.

This is through a soon to be launched mobile apps called Abizo and Kaizala for Android, iOS and Microsoft phones.

The apps allow parents of vaccinees to report the condition of their children.

It aims to provide vaccinees a prompt response and immediate medical attention by the local government.

“ This is not mandatory… Parents who are interested in tracing and monitoring the state of their children, whether away from home or at school can take advantage of these two kind of apps,” explained Education Secretary Leonor Briones.

“If there’s a parent (who) downloaded the app and registered the name of his or her child, lalabas doon kaagad iyong names. If he provided the LRN then verified agad na siya iyong parent. If he didn’t provide, that report will be segregated then throwback again to DOH for validation. Kapag na-verify then we include them under the category of private sector,” added Education Undersecretary Alain Del Pascua.

The monitoring apps are also expected to help identify areas that have high incidence of Dengvaxia vaccinees who are getting sick.

“There are a checklist of symptoms that they can just say, may lagnat, pannakit ng ulo…madali na. Sasabihin na lang doon saan mo dadalhin iyong bata. Anong service delivery, part of the network mo siya dadalhin,” said Health Secretary Francisco Duque III.

The Department of Education (DepEd) and other stakeholders assured that the National Privacy Act will protect the data sharing between DepEd and the Department of Health (DOH) in using the mobile apps.

Parents may officially use the mobile apps at the end of August. – Aiko Miguel / UNTV News and Rescue

DOH agrees with FDA decision to ban Dengvaxia in Phl

Maris Federez   •   August 22, 2019

A Filipino nurse prepares to administer an anti-dengue vaccine during a nationwide vaccination at a school in the flood-prone city of Marikina, east of Manila, Philippines, 04 April 2016. (Photoville International / FILE)

The Department of Health (DOH) has rejected the request of Sanofi Pasteur to overturn the decision of the Food and Drug Administration (FDA) to ban the use of Dengvaxia vaccine in the Philippines.

With this, the DOH approved the ruling of the FDA to permanently revoke the certificate of product registration of Dengvaxia for Sanofi’s failure to submit the necessary post-approval requirements.

“The decision concerns Sanofi’s complete disregard of FDA regulations, which were precisely put in place by law to ensure safety,” DOH Secretary Francisco Duque III said in a statement.

Although Sanofi was able to submit the first two versions of its risk management plans (RMP), the pharmaceutical company failed to submit the third and final version of the plan.

The DOH said, however, that Sanofi may apply for a new certificate of product registration (CPR) for Dengvaxia but this must be in accordance with the FDA regulations.

“Given that Dengvaxia is an innovative drug, the importance of complying with these post-marketing commitments is critical to public safety,” the statement added.

Meanwhile, the department has assured that it continues to address the increasing cases of dengue in the country. /mbmf

Sanofi Pasteur optimistic Dengvaxia will be restored in PH market

Aileen Cerrudo   •   August 15, 2019

French Pharmaceutical firm, Sanofi Pasteur expressed optimism that the Dengvaxia vaccine will be restored in the Philippine market.

In a statement, Sanofi Pasteur Philippines General Manager Jean Antoine Zinsou said they are open for a discussion with the Food and Drug Administration (FDA) and the Department of Health (DOH).

He also clarified that Dengvaxia is safe and effective to use.

According to Zinsou, the said vaccine was only banned in the Philippines because of incomplete documents or due to “administrative consideration.”

“We definitely need to settle this issue. One way to do it is to discuss with FDA and see what is needed to have this revocation lifted,” he said.

Zinsou also said Dengvaxia is registered in 20 countries across the globe and is acknowledged by the United States Food Drug Administration and the World Health Organization (WHO).

Meanwhile, Sanofi agrees with the DOH that Dengvaxia is not a solution to the Dengue epidemic in the country.

READ: Dengvaxia won’t bring dengue cases down – DOH

“The vaccines that we are mentioning is not a solution or a silver bullet for the ongoing outbreak. We are open to any discussion with the health authorities to see what is needed, what do they need for the future,” Zinsou said.

In February this year, the FDA revoked the certificate of product registration of Dengvaxia.

Sanofi already filed an appeal two weeks ago and the DOH will release their decision on the issue on August 19.—AAC (with reports from Aiko Miguel)

DOH belies bribery allegations by families of Dengvaxia vaccinees

Aileen Cerrudo   •   August 12, 2019

Families of children who had Dengvaxia vaccine rally in front of the Department of Health in Manila, 01 October 2018. (Photoville International)

The Department of Health (DOH) has belied the accusation made by families of Dengvaxia vaccinees that they received a P50,000 bribe from the department.

Health Secretary Francisco Duque III clarified that the P50,000 financial assistance did not come from the DOH.

“Iyang ayuda na iyan galing iyan sa Office of the President so hindi iyan galing sa DOH. Ito lamang ay dahil sa malasakit ng Pangulong Duterte para sa mga magulang na namatayan at gumastos para sa kanilang wake at paglibing at mga iba pang mga gastusin (That assistance came from the Office of the President, not the DOH. It was borne out of President Duterte’s concern for the parents of alleged Dengvaxia victims who had to pay for the wake, burial and other expenses),” he said.

This was after reports that several families of the Dengvaxia vaccinees are accusing the DOH of bribery after the department has offered them P50,000 financial assistance.

Several of them said they were asked to submit original documents and other information. They think these would be used as evidence in order to bring back the use of Dengvaxia amid the rise of dengue cases.—AAC (with reports from Aiko Miguel)

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+63) 396-8688 (Tel)

(+63) 2 920.8336 (Fax)

info@untvweb.com (General inquiries)

support@untvweb.com

UNTV News and Rescue Emergency Hotlines:

LANDLINE (+63) 396-8688

ADVERTISE WITH US

(+63) 2 442.6244 Loc. 143, 144, 162, 164

advertising@untvweb.com

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.